Hikma launches labetalol hydrochloride injection
In prefilled syringe form, labetalol hydrochloride is used in hospitals to treat severe hypertension and lower blood pressure.
Hikma is offering labetalol hydrochloride (labetalol HCl) injection in prefilled syringe form.
The 10 mg/2 ml PFS is used in hospitals to treat severe hypertension and lower blood pressure.
[Read more: Hikma to acquire Custopharm]
“Hikma is introducing the first 2 ml presentation to the market and we are pleased to expand our portfolio with this launch, broadening the choice of medicines available to hospitals,” the company said.
[Read more: Hikma intros Kloxxado]